Company intelligence
Erchonia Corporation
Quality Not Compromise.
About Erchonia Corporation
Erchonia was founded in 1996 as a small family business, and even though we’ve grown into an international enterprise, we still operate under the founding principles that guided us to our present success. Our commitment to the legitimate advancement of Low Level Laser Therapy (3LT®) through scientific and clinical research has transformed Erchonia Corporation into a world leader in the field of LLLT technology. The integrity, diligence, quality and commitment of our company are evident in the rigorous process we follow in order to take a research hypothesis from concept to viable, agency-approved product and treatment method. To ensure a steadfast adherence to our unique all-encompassing approach, our company serves as manufacturer, marketer, developer, promoter, creator and user of all our products.
Verified activity
Signals from Erchonia Corporation
2 published signals
Products & Services
Erchonia Corporation launched CLX™, a non-invasive laser technology designed to improve the appearance of submental fat for the chin and jawline.
Reported by Erchonia Corporation
Legal & Regulatory
Erchonia Corporation received FDA 510(k) clearance for the EVRL-DPN indication for prescription home use as an adjunctive treatment providing temporary relief of diabetic peripheral neuropathy foot pain.
Reported by Erchonia Corporation